chatbot

Artificial Intelligence, Startups, Health Tech, Providers, Physicians
Stacks on US $100 bill bundles in ascending order on white shelf, green background

Thunderstruck By OpenEvidence’s $12B Valuation? Don’t Be. 

OpenEvidence’s $12 billion valuation reflects investor confidence in its bottom-up, doctor-first model. It has driven rapid adoption, with more than 757,000 clinicians using the startup’s free AI medical search tool regularly. That scale is paired with targeted pharmaceutical advertising that’s already pushed the company past a $100 million revenue run rate.

presented by
Health Tech, Policy, Artificial Intelligence
Digital generated image of young woman wiht dark skin standing on grey ramp surrounded with multicoloured message chat icons trying to interact with them.

Faceless Advice, Real Consequences: The Challenge of AI Chatbots in Mental Health

As AI chatbots become a surrogate for human connection amid a national mental health crisis, experts are worried about these tools’ lack of safeguards — with research showing the models can provide dangerous, sometimes fatal, advice. Regulators and providers alike are scrambling to catch up with a technology that evolves faster than humans are able to understand.

presented by
presented by